US Paves Way for Novartis to Copy Amgen Biotech Drug
U.S. regulators have accepted an application by Sandoz - the generics arm of Novartis - seeking approval for a copycat version of Amgen's drug Neupogen, or filgrastim, for patients with low white blood cell counts.
Without Medicaid,Hospitals May Pay Patient Premiums
Uncompensated care was supposed to be a thing of the past, but it's persisting in many states not expanding Medicaid eligibility. As an alternative, for some high-cost uninsured patients, hospitals are turning to a new option.
CDC Lab Safety Point Person, Dr. Michael Bell, to Give Keynote on Hospital Safety at AJMCLive Event
Dr. Michael Bell, previously announced as the keynote speaker for the September 25-26 live meeting hosted by The American Journal of Managed Care, this weekend discussed his role in overhauling lab safety at the Centers for Disease Control and Prevention in Atlanta. Attendees at AJMCLive’s Atlanta conference, “Value-Based Decision-Making in Infectious Disease,” will have the chance to hear Dr. Bell discuss the prevention of hospital-acquired infections.
Appeals Courts Disagree Over Obamacare
Obamacare got taken for a roller-coaster ride on Tuesday when two different appeals courts took completely different takes on the latest challenges to the law.